Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review

December 2022 in “ Pharmacological Reviews ”

Edris Choupani, Mohammad Mahmoudi Gomari, Saeed Zanganeh, Sherko Nasseri, Kaveh Haji-Allahverdipoor, Neda Rostami, Yaeren Hernandez, Safa Najafi, Neda Saraygord‐Afshari, Arshad Hosseini

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on pharmrev.aspetjournals.org →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Safety of Oral Bicalutamide in Female Pattern Hair Loss: A Retrospective Review of 316 Patients

16 citations , March 2020 in “Journal of The American Academy of Dermatology”

Oral bicalutamide is safe and effective for female hair loss.

research Selective Androgen Receptor Modulators Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial-Mesenchymal Stem Cell Signaling

56 citations , July 2014 in “PloS one”

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

research Abstract P5-09-21: Selective Androgen Receptor Modulators (SARMs): Enobosarm as Targeted Therapy for the Treatment of Androgen Receptor-Positive Breast Cancer

2 citations , December 2013 in “Cancer research”

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

research Discovery of Nonsteroidal Androgens

209 citations , March 1998 in “Biochemical and biophysical research communications”

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.